India will soon start trials to test the safety, immunogenicity and efficacy after mixing doses of different brands of Covid-19 vaccines. While the trials will currently include Covaxin, Covishield and Sputnik-V, which currently have emergency use authorisation in the country, going forward the trials may also include jabs that are in the pipeline, senior officials said.
Posted from: this blog via Microsoft Power Automate.
